Reuters -- The U.S. Food and Drug Administration said on Tuesday AstraZeneca’s MedImmune unit is voluntarily recalling some of its H1N1 swine flu vaccine because it was not as potent as it should be.
Reuters -- The U.S. Food and Drug Administration said on Tuesday AstraZeneca’s MedImmune unit is voluntarily recalling some of its H1N1 swine flu vaccine because it was not as potent as it should be.
